Company news
Avalon GloboCare Corp. news in 2023
Avalon GloboCare Corp.'s news releases, calls and decks from 2023, newest first.
Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US
December 17, 2023
Avalon GloboCare Partners with Qi Diagnostics to Co-Develop International Multi-Center Clinical Studies for DKAir Breathalyzer Device for the Early Detection of Diabetic Ketoacidosis
October 17, 2023
Avalon’s Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device
September 12, 2023
Avalon GloboCare Announces Notice of Publication for Key U.S. Patent Filed Jointly with the Massachusetts Institute of Technology (MIT)
September 4, 2023
Avalon’s Laboratory Services MSO Launches Innovative Laboratory Test for Tuberculosis
August 29, 2023
Avalon’s Laboratory Services MSO Announces Expansion into Arizona
August 20, 2023
Avalon GloboCare’s Laboratory Services MSO Signs Exclusive In-Network Lab Services Agreement Providing Significant Expansion Opportunity into 21 States
July 18, 2023
Avalon GloboCare Provides Update on New Commercial Strategy
July 9, 2023
Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022
April 26, 2023
Avalon GloboCare Announces Commercial Launch of KetoAir Breathalyzer at the KetoCon Austin 2023 Conference
April 16, 2023
Avalon GloboCare Signs Agreement with Qi Diagnostics to Exclusively Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, U.K. and European Union
April 10, 2023
Avalon GloboCare Announces Closing of Strategic Investment in Laboratory Services MSO, a Leading Clinical Diagnostics and Reference Laboratory Company
February 12, 2023
Avalon GloboCare Announces Issuance of Key U.S. Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
January 16, 2023
Avalon GloboCare Appoints Lourdes Felix, CEO of a Premier Addiction Treatment Company, to its Board of Directors
January 10, 2023
Avalon GloboCare Announces the Deployment of Breakthrough Fusion Gene Map Technology
January 2, 2023
Decks in 2023
- Investor Presentation (June 2023)
Investor deck · 15 slides · Jun 16, 2023